Cathie Wood’s ARK sold $49 million in Signify stock after 32% surge

Two Cathie Wood funds, including her flagship ARK Innovation ETF ARKK, -0.34%, sold stock in Signify Health SGFY, -1.39% after the 32% surge on the back of a report it’s the target of a bidding war between Amazon AMZN, +0.30%, CVS Health CVS, -1.07% and UnitedHealth UNH, -1.65%. The ARK Innovation fund sold $31 million worth of Signify, and the ARK Genomic Revolution ETF sold $18 million. The estimated cost average in the ARK Innovation fund is $22.28, according to the Cathie’s Ark website, against Monday’s close of $28.